---
figid: PMC9334696__fnut-09-963413-g0002
figtitle: Biopolymeric nanoparticles based effective delivery of bioactive compounds
  toward the sustainable development of anticancerous therapeutics
organisms:
- Saccharomyces cerevisiae
- PX clade
- herbal medicine
- Curcuma longa
- Theobroma cacao
- Allium sativum
- Cannabis sativa
- Momordica charantia
- Chlorella vulgaris
- Hibiscus sabdariffa
- Phyllanthus emblica
- Cymbopogon citratus
- Arctium lappa
- Toona sinensis
- Echinacea purpurea
- Nephelium lappaceum
- Eclipta prostrata
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9334696
filename: fnut-09-963413-g0002.jpg
figlink: /pmc/articles/PMC9334696/figure/F2/
number: F2
caption: A schematic illustration of bioactive molecule sources and development, as
  well as their involvement in drug delivery systems and molecular mechanisms against
  different cancer cells. (A) Development of bioactive compounds; (B) Sources of biopolymers
  from plants, animals and microorganisms; (C) Mode of action of anticancerous molecules
  via TGF–β signaling pathway, death receptor, mitochondrial receptor–induced pathways
  against cancer cells; (D) A mechanism of suppressing tumor cells using biopolymers
  in conjunction with drugs; (E) The effect of bioactive molecules from plant extracts
  on the underlying mechanisms of cancer development [modified and adapted from Lin
  et al. ()]. ODC, Ornithine decarboxylase; DMBA, 7,12-Dimethylbenz(α)anthracene;
  Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein; NF-Kb, Transcription
  factor; p-ERK, Protein kinase RNA-like ER kinase; ROS, Reactive oxygen species;
  ENK, c-Jun-N terminal kinase; AIF, Apoptosis-inducing factor; FasL, Fas Ligand;
  ErbB3, Receptor tyrosine kinase; TGF-β, Transforming growth factor beta; ERK, Extracellular-signal-regulated
  kinase; AKT1, Serine/threonine-protein kinase; SMAD2, SMAD family member 2; Mdm2,
  Mouse double minute 2 homolog; PCNA, Proliferating cell nuclear antigen; p53 and
  p21, Tumor protein; WAF1/CIP1, Wildtype activating factor-1/cyclin-dependent kinase
  inhibitory protein-1; cdc2, Cell division cycle 2; HMGB1, High mobility group box
  1; Smac, Second mitochondria-derived activator of caspase; EndoG, Endonuclease G;
  ER, Endoplasmic reticulum; TRAIL, Tumor necrosis factor (TNF)-related apoptosis-inducing
  ligand; TNF RI, Tumor necrosis factor receptor 1; Rb, Retinoblastoma protein; PI3K,
  Phosphatidylinositol-3-kinase; uPA, Urokinase plasminogen activator; BP, Biopolymers.
papertitle: Biopolymeric nanoparticles based effective delivery of bioactive compounds
  toward the sustainable development of anticancerous therapeutics.
reftext: Neelam Pathak, et al. Front Nutr. 2022;9:963413.
year: '2022'
doi: 10.3389/fnut.2022.963413
journal_title: Frontiers in Nutrition
journal_nlm_ta: Front Nutr
publisher_name: Frontiers Media S.A.
keywords: biopolymeric nanoparticles | cancer treatment | drug delivery | nanomedicines
  | natural bioactives
automl_pathway: 0.5011343
figid_alias: PMC9334696__F2
figtype: Figure
redirect_from: /figures/PMC9334696__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9334696__fnut-09-963413-g0002.html
  '@type': Dataset
  description: A schematic illustration of bioactive molecule sources and development,
    as well as their involvement in drug delivery systems and molecular mechanisms
    against different cancer cells. (A) Development of bioactive compounds; (B) Sources
    of biopolymers from plants, animals and microorganisms; (C) Mode of action of
    anticancerous molecules via TGF–β signaling pathway, death receptor, mitochondrial
    receptor–induced pathways against cancer cells; (D) A mechanism of suppressing
    tumor cells using biopolymers in conjunction with drugs; (E) The effect of bioactive
    molecules from plant extracts on the underlying mechanisms of cancer development
    [modified and adapted from Lin et al. ()]. ODC, Ornithine decarboxylase; DMBA,
    7,12-Dimethylbenz(α)anthracene; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated
    X protein; NF-Kb, Transcription factor; p-ERK, Protein kinase RNA-like ER kinase;
    ROS, Reactive oxygen species; ENK, c-Jun-N terminal kinase; AIF, Apoptosis-inducing
    factor; FasL, Fas Ligand; ErbB3, Receptor tyrosine kinase; TGF-β, Transforming
    growth factor beta; ERK, Extracellular-signal-regulated kinase; AKT1, Serine/threonine-protein
    kinase; SMAD2, SMAD family member 2; Mdm2, Mouse double minute 2 homolog; PCNA,
    Proliferating cell nuclear antigen; p53 and p21, Tumor protein; WAF1/CIP1, Wildtype
    activating factor-1/cyclin-dependent kinase inhibitory protein-1; cdc2, Cell division
    cycle 2; HMGB1, High mobility group box 1; Smac, Second mitochondria-derived activator
    of caspase; EndoG, Endonuclease G; ER, Endoplasmic reticulum; TRAIL, Tumor necrosis
    factor (TNF)-related apoptosis-inducing ligand; TNF RI, Tumor necrosis factor
    receptor 1; Rb, Retinoblastoma protein; PI3K, Phosphatidylinositol-3-kinase; uPA,
    Urokinase plasminogen activator; BP, Biopolymers.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Triobp
  - 2610528J11Rik
  - Akt1
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Rho
  - Rhod
  - Ea2
  - Trp53
  - act
  - Fhl5
  - Acot7
  - Dbil5
  - Nr5a1
  - Efna5
  - Mapk8
  - Bax
  - Nkx3-1
  - OTULIN
  - TRIOBP
  - C1orf210
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - TP53
  - TP63
  - TP73
  - SERPINA3
  - ACTG1
  - ACTG2
  - FHL5
  - ACOT7
  - ACTBL2
  - POTEKP
  - POTEM
  - CPP
  - CTPP
  - NR5A1
  - BCR
  - IGKV3D-20
  - MAPK8
  - MAPK9
  - MAPK10
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - FASTK
  - FOXD3-AS1
  - BAX
  - gar
  - tara
  - as
  - temp
  - Cyp6a17
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - if
  - Capa
  - deg
  - Pa
  - Mmp1
  - Akt
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - bond
  - p53
  - betaTub60D
  - hth
  - rb
  - Act5C
  - .na.character
  - Act42A
  - Actbeta
  - 'On'
  - Egfr
  - form3
  - ali
  - alpha-Est7
  - gus
  - bsk
  - MKP-4
  - p38b
  - rl
---
